Cookson Peirce & Co’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-81,346
Closed -$22.1M 163
2015
Q3
$22.1M Hold
81,346
3.69% 1
2015
Q2
$24.7M Sell
81,346
-3,070
-4% -$916K 4.12% 2
2015
Q1
$25.1M Sell
84,416
-1,814
-2% -$517K 4.39% 2
2014
Q4
$22.2M Sell
86,230
-8,145
-9% -$2.04M 4.6% 1
2014
Q3
$22.8M Sell
94,375
-230
-0.2% -$51.5K 5.31% 1
2014
Q2
$21.1M Sell
94,605
-590
-0.6% -$122K 5.06% 1
2014
Q1
$19.6M Sell
95,195
-20,980
-18% -$4.16M 4.91% 1
2013
Q4
$19.5M Sell
116,175
-23,620
-17% -$3.69M 5.17% 1
2013
Q3
$20.1M Sell
139,795
-5,750
-4% -$766K 5.57% 1
2013
Q2
$18.4M Buy
+145,545
New +$16.5M 5.35% 2

Other funds holding AGN

Cookson Peirce & Co's AGN Position: Q4 2015 in Review

Cookson Peirce & Co sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 81,346 shares — an estimated $22.1M sold.

Cookson Peirce & Co first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $25.1M in Q1 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Cookson Peirce & Co reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Cookson Peirce & Co sold 81,346 Allergan plc shares in Q4 2015, an estimated $22.1M.
  • Cookson Peirce & Co first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
  • Cookson Peirce & Co's Allergan plc position peaked at $25.1M in Q1 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Cookson Peirce & Co's 13F filing for Q4 2015, filed 27 Jan 2016.